Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Clinical Nephrology

• Publication date

  1988-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 3063420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclosporin-associated nephropathy in patients with autoimmune diseases

  1988cited by this paper
• Risk factors for the development of chronic cyclosporine-nephrotoxicity.

  1988cited by this paper
• Long-term effects of cyclosporine on renal function in liver transplant recipients.

  1987cited by this paper
• Cyclosporine nephrotoxicity without major organ transplantation.

  1987cited by this paper
• Limited value of 111-indium platelet scintigraphy in renal transplant patients receiving cyclosporine.

  1986cited by this paper
• Renal histopathologic alterations in patients treated with cyclosporine for uveitis.

  1986cited by this paper
• Morphology of ciclosporin nephropathy.

  1986cited by this paper
• [Renal lesions induced by cyclosporin. Apropos of 4 renal biopsies and 22 necropsies of recipients of heart transplant].

  1986cited by this paper
• Cyclosporin-induced endothelial cell injury.

  1986cited by this paper
• Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.

  1986cited by this paper
• Haemolytic‐uraemic syndrome in recipients of bone marrow transplants not treated with cyclosporin A

  1986cited by this paper
• Cyclosporine-associated microangiopathy in renal transplantation: a severe but potentially reversible form of early graft injury.

  1986cited by this paper
• Cyclosporine nephrotoxicity.

  1986cited by this paper
• Glomerular thrombi in renal allografts associated with cyclosporin treatment.

  1985cited by this paper
• Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.

  1985cited by this paper
• Cyclosporine nephropathy after heart and heart-lung transplantation.

  1985cited by this paper
• Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period.

  1984cited by this paper
• Cyclosporine-associated chronic nephropathy.

  1984cited by this paper
• Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient.

  1984cited by this paper
• ABO-autoimmune hemolytic anemia in a renal transplant patient treated with cyclosporin. A case report.

  1984cited by this paper
• Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia.

  1983cited by this paper
• Nephrotoxicity in bone marrow transplant recipients treated with cyclpsporin A

  1983cited by this paper
• Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes

  1983cited by this paper
• Recurrence of haemolytic uraemic syndrome triggered by cyclosporin A after renal transplantation.

  1982cited by this paper
• Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.

  1981cited by this paper
• Cyclosporin-A prophylactic treatment of graft-versus-host disease in human allogeneic bone marrow transplantation: preliminary results.

  1981cited by this paper

• Calcineurin Is a Universal Regulator of Vessel Function—Focus on Vascular Smooth Muscle Cells

  2023cites this paper
• Clinical periodontal and dental findings in liver transplant patients: a systematic review and meta-analysis

  2020cites this paper
• Pathology of Kidney Transplantation

  2019cites this paper
• A molecular biopsy test based on arteriolar under‐hyalinosis reflects increased probability of rejection related to under‐immunosuppression

  2018cites this paper
• Hyalinosis Lesions in Renal Transplant Biopsies: Time‐Dependent Complexity of Interpretation

  2017cites this paper
• the setting of thrombotic microangiopathy Collapsing glomerulopathy is common in of the native kidney

  2016cites this paper
• СЛУЧАЙ ОСТРОЙ ТАКРОЛИМУС-ИНДУЦИРОВАННОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ У БОЛЬНОГО ПОСЛЕ ОРТОТОПИЧЕСКОЙ ТРАНСПЛАНТАЦИИ СЕРДЦА

  2016cites this paper
• Chronic Kidney Disease After Heart Transplantation: Risk Factors, Clinics, and Histopathology

  2016cites this paper
• Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney.

  2016cites this paper
• Evolution of allograft fibrosis and function in kidney transplant recipients: a retrospective analysis of stable patients under CNI and mTORi

  2015cites this paper
• Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?

  2014cites this paper
• Comparative models of transplant and non-transplant human kidney disease

  2012cites this paper
• Biopsy‐Diagnosed Renal Disease in Patients After Transplantation of Other Organs and Tissues

  2010cites this paper
• VALUE OF RESISTANCE INDEX FOR CYCLOSPORINE NEPHROTOXICITY IN RENAL TRANSPLANT PATIENTS

  2009cites this paper
• Medical complications of lung transplantation.

  2009cites this paper
• Gingival enlargement in pediatric organ transplant recipients in relation to tacrolimus-based immunosuppressive regimens.

  2009cites this paper
• Platelet CD61 expression in vascular calcineurin inhibitor toxicity of renal allografts.

  2008cites this paper
• Dietary Electrolytes and Cyclosporine Toxicity Experimental studies in spontaneously hypertensive rats

  2008cites this paper
• Nephrotoxicity of calcineurin and mTOR inhibitors

  2008cites this paper
• Chapter 24 – Pathology of Kidney Transplantation

  2008cites this paper
• Incidence and predictors of delayed chronic kidney disease in long‐term survivors of hematopoietic cell transplantation

  2008cites this paper
• Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity.

  2007cites this paper
• Case 12-2007 : A 56-year-old woman with renal failure after heart-lung transplantation

  2007cites this paper
• Case records of the Massachusetts General Hospital. Case 12-2007. A 56-year-old woman with renal failure after heart-lung transplantation.

  2007cites this paper
• Approving the vagus-nerve stimulator for depression.

  2007cites this paper
• Acute renal failure in the setting of bone marrow transplantation Principal discussant :

  2007cites this paper
• Reproducibility Studies on Arteriolar Hyaline Thickening Scoring in Calcineurin Inhibitor‐Treated Renal Allograft Recipients

  2006cites this paper
• Sirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results

  2006cites this paper
• Long‐term course of post‐transplant mesangial IgA deposition: clinicopathologic study of nine cases

  2005cites this paper
• Arteriolosclerosis of the human renal allograft: morphology, origin, life history and relationship to cyclosporine therapy

  2005cites this paper
• Posttransplantation chronic renal damage in nonrenal transplant recipients.

  2005cites this paper
• Ocular Irritation Following Frequent Applications of Cyclosporinea

  2005cites this paper
• Anti–Transforming Growth Factor Antibody at Low but Not High Doses Limits Cyclosporine-Mediated Nephrotoxicity Without Altering Rat Cardiac Allograft Survival: Potential of Therapeutic Applications

  2004cites this paper
• The pathophysiology of Sandimmune (cyclosporine) in man and animals

  2004cites this paper
• Benefit-Risk Assessment of Ciclosporin Withdrawal in Renal Transplant Recipients

  2004cites this paper
• Calcineurin inhibitors and sirolimus

  2003cites this paper
• Analysis of transforming growth factor-&bgr; and profibrogenic molecules in a rat cardiac allograft model treated with cyclosporine1

  2002cites this paper
• Cyclosporine reduces left ventricular mass with chronic aortic banding in mice, which could be due to apoptosis and fibrosis.

  2001cites this paper
• The lady who had a remote history of ovarian malignancy and developed thrombotic microangiopathy.

  2000cites this paper
• Thrombotic microangiopathy (TMA) (1) GVHD標的臓器におけるTMAの発生

  2000cites this paper
• Cyclosporine-associated thrombotic microangiopathy in renal allografts.

  1999cites this paper
• Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.

  1999cites this paper
• Immunosuppressant-Induced Nephropathy

  1999cites this paper
• Renal failure in the recipients of nonrenal solid organ transplants.

  1999cites this paper
• Clinical Nephrotoxins

  1998cites this paper
• Cyclosporine/tacrolimus (FK-506)

  1998cites this paper
• Detrimental effect of dietary sodium and beneficial effect of dietary magnesium on glomerular changes in cyclosporin-A-treated spontaneously hypertensive rats.

  1998cites this paper
• De novo collapsing glomerulopathy in renal allografts.

  1998cites this paper
• Renal toxicities of antineoplastic drugs and bone marrow transplantation.

  1997cites this paper
• Cyclosporine in the therapy of steroid-resistant idiopathic nephrotic syndrome.

  1997cites this paper
• Renal disease in hepatitis C-positive liver transplant recipients.

  1997cites this paper
• A randomized controlled trial of verapamil on cyclosporine nephrotoxicity in heart and lung transplant recipients.

  1997cites this paper
• Thrombotic microangiopathic syndromes after bone marrow transplantation.

  1996cites this paper
• Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy.

  1996cites this paper
• Renal fibrosis in cyclosporin A-treated renal allograft recipients: morphological findings in relation to renal hemodynamics

  1996cites this paper
• Chronic cyclosporine nephrotoxicity in rheumatoid arthritis.

  1996cites this paper
• Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy.

  1996cites this paper
• Cyclosporine induces glomerulosclerosis: three-dimensional definition of the lesions in a rat model of renal transplant.

  1996cites this paper
• Mechanisms of acute and chronic nephrotoxicity from immunosuppressive drugs.

  1996cites this paper
• Cyclosporine nephropathy: pathophysiology and clinical impact.

  1996cites this paper
• Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.

  1995cites this paper
• Sustained vasoconstriction associated with daily cyclosporine dose in heart and lung transplant recipients: potential pathophysiologic role of endothelin.

  1995cites this paper
• Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy.

  1995cites this paper
• Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity.

  1995cites this paper
• The renal-cardiac connection: renal parenchymal alterations in patients with heart disease.

  1994cites this paper
• Cyclosporine in the treatment of idiopathic nephrosis.

  1994cites this paper
• [Is nephrotoxicity of cyclosporine ineluctable?].

  1994cites this paper
• Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine.

  1994cites this paper
• Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis.

  1994cites this paper
• Acute renal failure in the setting of bone marrow transplantation.

  1994cites this paper
• Lipid abnormalities in red blood cell and plasma phospholipids in cyclosporine-treated heart transplant recipients.

  1994cites this paper
• Acute renal failure in the setting of bone marrow transplatation

  1994cites this paper
• Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.

  1993cites this paper
• The pathology of bone marrow transplantation

  1993cites this paper
• Cyclosporine-associated thrombotic microangiopathy: report of two cases with good outcome and successful subsequent reuse.

  1993cites this paper
• Mesangial immunoglobulin A deposition and focal glomerulosclerosis in a renal transplant patient with nephrotic syndrome--Berger's disease alone or superimposition of focal glomerulosclerosis?

  1993cites this paper
• Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses.

  1993cites this paper
• Cyclosporin in primary haploidentical live-donor kidney transplantation: is it worthwhile?

  1993cites this paper
• Prospective randomized study of azathioprine versus cyclosporin in live-donor kidney transplantation.

  1993cites this paper
• RENAL TRANSPLANT FUNCTION AFTER TEN YEARS OF CYCLOSPORINE

  1992cites this paper
• Reversible cyclosporine arteriolopathy.

  1992cites this paper
• Effect of reduced cyclosporin dosage on long‐term renal allograft histology

  1992cites this paper
• Long-term results of cyclosporin A therapy in children.

  1992cites this paper
• Successful renal transplantation after cyclosporine-associated hemolytic-uremic syndrome following bilateral lung transplantation.

  1992cites this paper
• Effect of reduced cyclosporin dosage on long-term renal allograft histology

  1992cites this paper
• The efficacy and tolerability of cyclosporine G in human kidney transplant recipients.

  1992cites this paper
• Cyclosporine and the renin-angiotensin system.

  1991cites this paper
• Cyclosporine-induced renal dysfunction in experimental animals and humans.

  1991cites this paper
• Evolution of Cyclosporin Nephrotoxicity

  1991cites this paper
• Altered Renovascular Endothelial Functions During Nephrotoxicity

  1991cites this paper
• The pathophysiology of sandimmune (cyclosporine) in man and animals

  1990cites this paper
• von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patients.

  1990cites this paper
• Cellular and molecular mechanisms of cyclosporin nephrotoxicity.

  1990cites this paper
• Thrombotic microangiopathy with reversible acute renal failure in a cardiac transplant recipient under cyclosporin.

  1990cites this paper
• Hemolytic uremic syndrome in patients with Behçet's disease treated with cyclosporin A: report of 2 cases.

  1990cites this paper
• The spectrum of ciclosporin nephrotoxicity.

  1990cites this paper
• Renal side‐effects of cyclosporin A with special reference to autoimmune diseases

  1990cites this paper
• Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients.

  1990cites this paper
• Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up.

  1990cites this paper
• GLOMERULOTUBULAR FUNCTION IN LONG‐TERM RENAL ALLOGRAFT RECIPIENTS: A COMPARISON OF CONVENTIONAL THERAPY WITH CYCLOSPORINE

  1990cites this paper